Buprenorphine 20 ug/h (Buprenorphine PATCH, EXTENDED RELEASE) 20 ug/h

Buprenorphine 20 ug/h is a transdermal patch designed for extended-release pain management. This medication is used to alleviate moderate to severe chronic pain over an extended period.

Strength

20 ug/h

Pack Size

4 POUCH in 1 CARTON (0093-3659-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Buprenorphine 20 ug/h is primarily used for the management of chronic pain that requires around-the-clock, long-term opioid treatment. The patch delivers a consistent dose of buprenorphine through the skin, providing sustained pain relief. It is often prescribed for conditions where other pain medications are not effective or suitable. Buprenorphine patches are designed to release the medication over 168 hours, ensuring continuous pain management.

Side Effects

Common effects of using Buprenorphine 20 ug/h may include skin irritation at the application site, nausea, constipation, and dizziness. Some users may experience drowsiness or headaches. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

Buprenorphine 20 ug/h should be applied to clean, dry, and intact skin. Avoid applying the patch to areas with hair or irritations. It is important to follow the healthcare provider's instructions for proper application and removal. Keep the patch out of reach of children and pets. Always consult a healthcare professional before starting or stopping any medication.

Avoid Interactions

Buprenorphine 20 ug/h may interact with other medications, including sedatives, tranquilizers, and alcohol. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Combining buprenorphine with other central nervous system depressants can increase the risk of side effects.

Frequently Asked Questions

Buprenorphine 20 ug/h is used for the management of moderate to severe chronic pain that requires long-term opioid treatment.

The Buprenorphine 20 ug/h patch is designed to release medication over a period of 168 hours, or seven days.

The patch should be applied to clean, dry, and intact skin, avoiding areas with hair or irritations.

If you experience skin irritation, remove the patch and consult your healthcare provider for further guidance.

It is generally advised to avoid alcohol while using Buprenorphine 20 ug/h, as it may increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.